全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Cancers  2012 

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)

DOI: 10.3390/cancers4041161

Keywords: acute myeloid leukemia, targeted therapies, early phase trials

Full-Text   Cite this paper   Add to My Lib

Abstract:

Acute myeloid leukemia (AML) is nearly always a fatal malignancy. For the past 40 years, the standard of care remains a combination of cytarabine and an anthracycline known as 7 + 3. This treatment regimen is troubled by both low survival rates (10% at 5 years) and deaths due to toxicity. Substantial new laboratory findings over the past decade have identified many cellular pathways that contribute to leukemogenesis. These studies have led to the development of novel agents designed to target these pathways. Here we discuss the molecular underpinnings and clinical benefits of these novel treatment strategies. Most importantly these studies demonstrate that clinical response is best achieved by stratifying each patient based on a detailed understanding of their molecular abnormalities.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133